Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). BB Biotech AG's share price for the quarter that ended in Dec. 2023 was $76.0579. BB Biotech AG's Shares Outstanding (EOP) for the quarter that ended in Dec. 2023 was 54.85 Mil. Therefore, BB Biotech AG's market cap for the quarter that ended in Dec. 2023 was $4,171.47 Mil.
BB Biotech AG's quarterly market cap
stayed the same
from Jun. 2023 ($4,171.47 Mil) to Sep. 2023 ($4,171.47 Mil) and
stayed the same
from Sep. 2023 ($4,171.47 Mil) to Dec. 2023 ($4,171.47 Mil).
BB Biotech AG's annual market cap
declined
from Dec. 2021 ($4,205.44 Mil) to Dec. 2022 ($4,171.47 Mil) but then
stayed the same
from Dec. 2022 ($4,171.47 Mil) to Dec. 2023 ($4,171.47 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. BB Biotech AG's Enterprise Value for Today is $2,767.58 Mil.
BB Biotech AG Market Cap Historical Data
The historical data trend for BB Biotech AG's Market Cap can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of BB Biotech AG's Market Cap
For the Biotechnology subindustry, BB Biotech AG's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
BB Biotech AG's Market Cap Distribution in the Biotechnology Industry
For the Biotechnology industry and Healthcare sector, BB Biotech AG's Market Cap distribution charts can be found below:
* The bar in red indicates where BB Biotech AG's Market Cap falls into.
BB Biotech AG Market Cap Calculation
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
BB Biotech AG's Market Cap for the fiscal year that ended in Dec. 2023 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BB Biotech AG (GREY:BBAGF) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
BB Biotech AG Market Cap Related Terms
Thank you for viewing the detailed overview of BB Biotech AG's Market Cap provided by GuruFocus.com. Please click on the following links to see related term pages.
BB Biotech AG (BB Biotech AG) Business Description
BB Biotech AG is a part of the healthcare sector in Switzerland. Its primary activity includes making investments, especially in the biotechnology market and is one of the largest investors in the field of biotechnology. The focus of the investments is on those listed companies that focus on the development and marketing of novel drugs with a clear value for the healthcare system. BB Biotech follows a strategy of carefully screening and selecting biotechnology firms with a long-term time horizon and having established products in the marketplace. Geographically it earns key revenue from the Netherlands.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
BBAGF has been successfully added to your 